| Manufacturing Exosomes: A Promising Therapeutic Platform | 2018/03/01 | English | 260 |
| 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications | 2005/12/01 | English | 257 |
| Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines | 2019/02/01 | English | 255 |
| Osteoclasts: more than ‘bone eaters’ | 2014/08/01 | English | 255 |
| The immunomodulatory capacity of mesenchymal stem cells | 2012/02/01 | English | 254 |
| Epithelial–mesenchymal transition and the invasive potential of tumors | 2008/05/01 | English | 252 |
| TAT transduction: the molecular mechanism and therapeutic prospects | 2007/10/01 | English | 252 |
| ‘Cancer associated fibroblasts’ – more than meets the eye | 2013/08/01 | English | 251 |
| Chromatin remodeling and cancer, part I: covalent histone modifications | 2007/09/01 | English | 250 |
| The Immunopathophysiology of Endometriosis | 2018/09/01 | English | 247 |
| MLL: a histone methyltransferase disrupted in leukemia | 2004/10/01 | English | 246 |
| Pathogenesis of human systemic lupus erythematosus: recent advances | 2010/02/01 | English | 243 |
| Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies | 2021/04/01 | English | 241 |
| Epigenetic mechanisms in drug addiction | 2008/08/01 | English | 238 |
| Type 2 diabetes as a protein misfolding disease | 2015/07/01 | English | 233 |
| Targeting the mTOR signaling network in cancer | 2007/10/01 | English | 232 |
| The emerging biology of satellite cells and their therapeutic potential | 2008/02/01 | English | 230 |
| p38 MAP kinase: a convergence point in cancer therapy | 2004/03/01 | English | 230 |
| Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy | 2005/04/01 | English | 229 |
| Mitophagy and Neuroprotection | 2020/01/01 | English | 228 |
| Vesicular stomatitis virus: re-inventing the bullet | 2004/05/01 | English | 226 |
| Induced pluripotent stem cells: current progress and potential for regenerative medicine | 2009/02/01 | English | 220 |
| Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers? | 2004/10/01 | English | 220 |
| The peripheral-blood transcriptome: new insights into disease and risk assessment | 2007/10/01 | English | 217 |
| Redefining the gut as the motor of critical illness | 2014/04/01 | English | 216 |
| Nanosensors and nanomaterials for monitoring glucose in diabetes | 2010/12/01 | English | 216 |
| Vascular calcification and bone disease: the calcification paradox | 2009/09/01 | English | 214 |
| Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization | 2013/04/01 | English | 213 |
| Thymosin β: actin-sequestering protein moonlights to repair injured tissues | 2005/09/01 | English | 210 |
| TRAIL on trial: preclinical advances in cancer therapy | 2013/11/01 | English | 209 |